ResearcherWashington University in St. LouisNo recent work listed
Joel Picus
Matched on ORCID iD 0000-0002-4038-936X; OpenAlex author ID A5034354367. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2010: 1 trial · 2011: none · 2012: 2 papers · 2013: 1 paper
Papers 3
- A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1007/s10637-012-9866-y↗
- Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreati… Co-author DOI 10.1002/cam4.27↗
- Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma. Co-author DOI 10.6092/1590-8577/913↗
Trials 1
- Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer Principal investigator NCT01080248↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Steven M. Sorscher · 2 shared papers, 2012–2013 · strength 0.06
- Benjamin R. Tan · 2 shared papers, 2012–2013 · strength 0.06
- Albert Craig Lockhart · 2 shared papers, 2012–2013 · strength 0.06
- Andrea Wang‐Gillam · 2 shared papers, 2012–2013 · strength 0.06
- William G. Hawkins · 1 shared paper, 2013 · strength 0.03
- John R. Hornick · 1 shared paper, 2013 · strength 0.03
- Peter S. Goedegebuure · 1 shared paper, 2013 · strength 0.03
- David C. Linehan · 1 shared paper, 2012 · strength 0.03
- John J. Arcaroli · 1 shared paper, 2012 · strength 0.03
- Feng Gao · 1 shared paper, 2012 · strength 0.03
- Parvin F. Peddi · 1 shared paper, 2012 · strength 0.03
- Manuel M. Hidalgo · 1 shared paper, 2012 · strength 0.03
- Charles Erlichman · 1 shared paper, 2012 · strength 0.03
- Robert R. McWilliams · 1 shared paper, 2012 · strength 0.03
- Wells A. Messersmith · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.